Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2902)
All Articles published online
|
Feb 28, 2005 (publication date) through May 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nan KJ, Guo H, Ruan ZP, Jing Z, Liu SX. Expression of p57kip2 and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma. World J Gastroenterol 2005; 11(8): 1237-1240 [PMID: 15754413 DOI: 10.3748/wjg.v11.i8.1237] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i8/1237.htm |
| Number | Citing Articles |
| 1 |
Chengcheng Yang, Haocheng Nan, Jiequn Ma, Lili Jiang, Qianqian Guo, Lili Han, Yamin Zhang, Kejun Nan, Hui Guo. High Skp2/Low p57Kip2 Expression is Associated with Poor Prognosis in Human Breast Carcinoma. Breast Cancer: Basic and Clinical Research 2015; : BCBCR.S30101 doi: 10.4137/BCBCR.S30101
|
| 2 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3173 doi: 10.1007/978-3-319-26956-6_174
|
| 3 |
Pınar Atasoy, Erdal Yilmaz, Onder Bozdogan, Sebnem Ayva, Ertan Batislam. Expression profile and prognostic importance in prostate lesions of the reverse transcriptase component of human telomerase (hTERT) and of cyclin-dependent kinase inhibitor p57 (p57kip2a). International Urology and Nephrology 2009; 41(1): 55 doi: 10.1007/s11255-008-9399-7
|
| 4 |
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic review. European Journal of Cancer 2007; 43(6): 979 doi: 10.1016/j.ejca.2007.01.004
|
| 5 |
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget 2017; 8(8): 14192 doi: 10.18632/oncotarget.13929
|
| 6 |
Ruth Holm, Mette Førsund, Mai T. Nguyen, Jahn M. Nesland, Claes G. Trope, John Matthew Koomen. Expression of p15INK4b and p57KIP2 and Relationship with Clinicopathological Features and Prognosis in Patients with Vulvar Squamous Cell Carcinoma. PLoS ONE 2013; 8(4): e61273 doi: 10.1371/journal.pone.0061273
|
| 7 |
Yan Zhang, Xiaohong He, Xiaolin Chen, Hong Ma, Donghong Liu, Jinyun Luo, Zhimin Du, Yafei Jin, Yan Xiong, Jiangui He, Dianqiu Fang, Kuijian Wang, William E. Lawson, John C.K. Hui, Zhensheng Zheng, Guifu Wu. Enhanced External Counterpulsation Inhibits Intimal Hyperplasia by Modifying Shear Stress–Responsive Gene Expression in Hypercholesterolemic Pigs. Circulation 2007; 116(5): 526 doi: 10.1161/CIRCULATIONAHA.106.647248
|
| 8 |
Ioannis S. Pateras, Kalliopi Apostolopoulou, Katerina Niforou, Athanassios Kotsinas, Vassilis G. Gorgoulis. p57KIP2: “Kip”ing the Cell under Control. Molecular Cancer Research 2009; 7(12): 1902 doi: 10.1158/1541-7786.MCR-09-0317
|
| 9 |
Thomas P.J. Hofer, Marion Frankenberger, Karl J. Staples, Löms Ziegler-Heitbrock. Expression of p57-Kip2 in monocytes and macrophages. Immunobiology 2006; 211(6-8): 455 doi: 10.1016/j.imbio.2006.05.018
|
| 10 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_174-1
|
| 11 |
P Vlachos, B Joseph. The Cdk inhibitor p57Kip2 controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics. Oncogene 2009; 28(47): 4175 doi: 10.1038/onc.2009.269
|
| 12 |
ABDU SELIM HAMID, JINRAN LI, YALI WANG, XIAODONG WU, HASSAN ABDELLAH AHMED ALI, ZHENWU DU, LIHUA BO, YUCHENG ZHANG, GUIZHEN ZHANG. Recombinant human decorin upregulates p57KIP2 expression in HepG2 hepatoma cell lines. Molecular Medicine Reports 2013; 8(2): 511 doi: 10.3892/mmr.2013.1510
|
| 13 |
Yun Xiao, Xia Li, Yueying Yang, Yadong Wang, Shaoqi Rao. Cell cycle-dependent gene networks relevant to cancer. Progress in Natural Science 2008; 18(8): 945 doi: 10.1016/j.pnsc.2008.03.003
|
| 14 |
Önder Bozdoğan, Pinar Atasoy, Ertan Batislam, M Murad Başar, Halil Başar. Significance of p57Kip2 Down-Regulation in Oncogenesis of Bladder Carcinoma: An Immunohistochemical Study. Tumori Journal 2008; 94(4): 556 doi: 10.1177/030089160809400418
|
| 15 |
Ren Jie Jin, Yongsoo Lho, Yongqing Wang, Mingfang Ao, Monica Patricia Revelo, Simon W. Hayward, Marcia L. Wills, Susan K. Logan, Pumin Zhang, Robert J. Matusik. Down-regulation of p57Kip2 Induces Prostate Cancer in the Mouse. Cancer Research 2008; 68(10): 3601 doi: 10.1158/0008-5472.CAN-08-0073
|
| 16 |
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
|
| 17 |
F Fornari, L Gramantieri, M Ferracin, A Veronese, S Sabbioni, G A Calin, G L Grazi, C Giovannini, C M Croce, L Bolondi, M Negrini. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008; 27(43): 5651 doi: 10.1038/onc.2008.178
|